“We look forward to engaging with the U.S. Food and Drug Administration and other regulatory authorities as we seek to advance the development of this potentially disease modifying therapy for individuals living with MSA.”
Im not a Scientist so i’m happy to read others opinions
Simple Question ?
All this info re 50 mg against 75 mg etc ( discrepancy)
this info was out there when we raised $40 million
Note..
Don’t you think that JPMorgan Chase .. Regal…Blackrock would have done their DD? Before investing..
- Forums
- ASX - By Stock
- Ann: Alterity Presents Encouraging New Phase 2 Data in MSA
ATH
alterity therapeutics limited
Add to My Watchlist
0.00%
!
1.1¢

“We look forward to engaging with the U.S. Food and Drug...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $60.81K | 5.737M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 16255465 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 1643984 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 9305965 | 0.010 |
30 | 26756594 | 0.009 |
15 | 25470226 | 0.008 |
12 | 23772392 | 0.007 |
15 | 24953518 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 1643984 | 2 |
0.012 | 20418298 | 32 |
0.013 | 7744325 | 14 |
0.014 | 13188180 | 7 |
0.015 | 2059976 | 9 |
Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |